The Latest Breaking News from CMS

There are no drugs or treatments to cure Alzheimer’s disease, but emerging drugs may slow disease progression.

MIAMI — Mary Zhelyazkova was surprised when pharmacists at Florida’s largest safety net hospital said they could not fill her prescription.

Biogen stock jumped into a buy zone Thursday after Medicare officials said they would pay for some Alzheimer's treatments.

Until recently, Jonathon Murray relied on Medicaid to pay for treatments for multiple health conditions, including chronic insomnia. Murray, a 20-year-old restaurant worker from the college town of Brookings, South Dakota, said that without his medication, he would stay awake for several nights in a row.

WASHINGTON — Medicare Advantage plans lure customers with television ads promising plans with dental, vision and hearing benefits that traditional Medicare doesn’t offer

Software as a Service (SaaS) has been a popular business model in the IT sector for years and is now rapidly expanding in the digital signage world, delivering unmatched benefits for end users and AV integrators alike. However, true digital signage SaaS solutions are few and far between.

Though supplemental benefits often draw seniors to Medicare Advantage plans, insurance experts question their value.

Millions of patients and their caregivers breathed a collective sigh of relief when drugmaker Eli Lilly recently announced its new experimental Alzheimer’s medication appears to slow cognitive decline by 35%. The Food and Drug Administration could approve the new treatment, donanemab, as soon as this year.

Georgia is the latest state to enact a law that allows hospitals to create independent police forces. Critics worry the law enforcement focus could have unintended consequences.